Neomycin is an antibiotic that interferes with bacterial protein synthesis by binding primarily to the 30S subunit of bacterial ribosomes. Many vaccines contain trace amounts of neomycin to ...

In preclinical studies using mice with advanced colorectal cancer and melanoma (skin cancer), the bacterial vaccine was able to boost the immune system enough to suppress tumor growth, and in many ...

Antibiotic alternatives are needed for controlling diseases that cause high mortality. A vaccine discovery for Clostridial dermatitis in turkeys could lead to developing improved prophylactic ...

Sanofi SA (NASDAQ:SNY) and Johnson & Johnson (NYSE:JNJ) have discontinued the E.mbrace phase 3 study evaluating a vaccine candidate for extraintestinal pathogenic E. coli. The E.mbrace study is a ...